Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (41-50 of 953) with videos related to

Pageof 96
Sort By:
Neurology|January 28, 2004
White matter lesions and hippocampal atrophy in Alzheimer's diseaseFrank-Erik de Leeuw, Frederik Barkhof, Philip Scheltens
Journal of Aging Research|April 14, 2012
White matter changes: new perspectives on imaging, clinical aspects, and interventionSofia Madureira, Ana Verdelho, Leonardo Pantoni, et al.
Annals of Neurology|April 1, 2003
Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patientsDaniela Galimberti, Niki Schoonenboom, Elio Scarpini, et al.
Nature Medicine|August 10, 2004
Advances in the early detection of Alzheimer's diseasePeter J Nestor, Philip Scheltens, John R Hodges
Alzheimer'S Research & Therapy|April 15, 2010
Can novel therapeutics halt the amyloid cascade?Niels D Prins, Pieter Jelle Visser, Philip Scheltens
Journal of Alzheimer'S Disease : JAD|November 26, 2002
Head trauma and Alzheimer's diseaseRishi D S Nandoe, Philip Scheltens, Piet Eikelenboom
Topics in Magnetic Resonance Imaging : TMRI|July 26, 2005
Pathological aging of the brain: an overviewAntónio J Bastos Leite, Philip Scheltens, Frederik Barkhof
The Lancet. Neurology|July 10, 2003
Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusionPhilip Scheltens, Nick Fox, Frederik Barkhof, et al.
Annals of the New York Academy of Sciences|April 7, 2007
Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRIWiesje M van der Flier, Frederik Barkhof, Philip Scheltens
Dementia and Geriatric Cognitive Disorders|April 1, 2020
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic RevisitedLeo Boelaarts, Jos F M de Jonghe, Philip Scheltens
Pageof 96

Showing results (41-50 of 953) with videos related to

Sort By:
Pageof 96
Neurology|January 28, 2004
White matter lesions and hippocampal atrophy in Alzheimer's diseaseFrank-Erik de Leeuw, Frederik Barkhof, Philip Scheltens
Journal of Aging Research|April 14, 2012
White matter changes: new perspectives on imaging, clinical aspects, and interventionSofia Madureira, Ana Verdelho, Leonardo Pantoni, et al.
Annals of Neurology|April 1, 2003
Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patientsDaniela Galimberti, Niki Schoonenboom, Elio Scarpini, et al.
Nature Medicine|August 10, 2004
Advances in the early detection of Alzheimer's diseasePeter J Nestor, Philip Scheltens, John R Hodges
Alzheimer'S Research & Therapy|April 15, 2010
Can novel therapeutics halt the amyloid cascade?Niels D Prins, Pieter Jelle Visser, Philip Scheltens
Journal of Alzheimer'S Disease : JAD|November 26, 2002
Head trauma and Alzheimer's diseaseRishi D S Nandoe, Philip Scheltens, Piet Eikelenboom
Topics in Magnetic Resonance Imaging : TMRI|July 26, 2005
Pathological aging of the brain: an overviewAntónio J Bastos Leite, Philip Scheltens, Frederik Barkhof
The Lancet. Neurology|July 10, 2003
Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusionPhilip Scheltens, Nick Fox, Frederik Barkhof, et al.
Annals of the New York Academy of Sciences|April 7, 2007
Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRIWiesje M van der Flier, Frederik Barkhof, Philip Scheltens
Dementia and Geriatric Cognitive Disorders|April 1, 2020
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic RevisitedLeo Boelaarts, Jos F M de Jonghe, Philip Scheltens
Pageof 96